tiprankstipranks
Trending News
More News >
IMCD N.V. (NL:IMCD)
:IMCD
Advertisement

IMCD N.V. (IMCD) AI Stock Analysis

Compare
8 Followers

Top Page

NL:IMCD

IMCD N.V.

(IMCD)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
€103.00
▲(11.23% Upside)
The overall stock score of 72 reflects strong financial performance with robust revenue growth and profitability, though operational efficiency and leverage management need improvement. Technical analysis indicates mixed signals with short-term bullish momentum but potential overbought conditions. Valuation is fair, with a reasonable P/E ratio and moderate dividend yield.

IMCD N.V. (IMCD) vs. iShares MSCI Netherlands ETF (EWN)

IMCD N.V. Business Overview & Revenue Model

Company DescriptionIMCD N.V. is a leading global distributor of specialty chemicals and food ingredients, operating across various sectors including pharmaceuticals, personal care, food and nutrition, and industrial applications. With a robust portfolio of products and a strong focus on delivering value-added services, IMCD partners with manufacturers to provide tailored solutions that meet the specific needs of its customers. The company’s extensive network and expertise in market development enable it to effectively connect suppliers and customers, driving growth and innovation within its sectors.
How the Company Makes MoneyIMCD generates revenue primarily through the distribution of specialty chemicals and food ingredients. The company operates on a model that involves purchasing products from manufacturers and selling them to customers, earning a margin on each transaction. Key revenue streams include sales of chemicals across various sectors, such as pharmaceuticals, where they supply active pharmaceutical ingredients (APIs) and excipients, and personal care, where they provide cosmetic ingredients. Additionally, IMCD offers technical support and formulation services, which further enhance customer relationships and drive sales. Significant partnerships with leading manufacturers allow IMCD to expand its product offerings and maintain a competitive edge in the market, contributing to its overall earnings.

IMCD N.V. Financial Statement Overview

Summary
IMCD N.V. demonstrates strong revenue growth and profitability. However, there are concerns about increased leverage and declining free cash flow, indicating potential liquidity challenges.
Income Statement
82
Very Positive
The company has demonstrated steady revenue growth with a 6.4% increase from 2023 to 2024. Gross profit margin is strong at 25.4%, and the net profit margin is relatively healthy at 5.9%. However, there is a slight decline in EBIT margin from 9.6% in 2023 to 9.0% in 2024, indicating a potential area for operational improvement.
Balance Sheet
76
Positive
The debt-to-equity ratio has increased to 0.78, reflecting higher leverage, which could pose risks if not managed carefully. However, the company maintains a strong equity ratio of 45.4%, indicating a solid capital structure. Return on equity remains robust at 12.6%, reflecting effective use of shareholder funds.
Cash Flow
70
Positive
There is a significant decrease in free cash flow from 2023 to 2024, with a free cash flow growth rate of -33.9%. The operating cash flow to net income ratio is 1.0, indicating decent cash generation relative to net income. The decline in free cash flow suggests potential challenges in maintaining liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.83B4.73B4.44B4.60B3.44B2.77B
Gross Profit904.19M1.20B1.12B1.15B836.32M647.48M
EBITDA588.65M589.14M566.90M574.63M394.79M258.23M
Net Income266.69M278.24M292.27M313.08M207.28M120.13M
Balance Sheet
Total Assets4.63B4.88B4.15B3.64B3.27B2.71B
Cash, Cash Equivalents and Short-Term Investments190.43M522.78M394.46M222.00M177.88M169.01M
Total Debt1.73B1.73B1.28B722.60M409.63M691.22M
Total Liabilities2.65B2.66B2.43B1.97B1.81B1.45B
Stockholders Equity1.98B2.21B1.72B1.67B1.46B1.26B
Cash Flow
Free Cash Flow227.10M252.76M382.54M277.58M177.55M220.04M
Operating Cash Flow239.85M279.21M420.01M298.84M196.26M242.37M
Investing Cash Flow-375.49M-387.95M-394.59M-255.36M-196.13M-394.30M
Financing Cash Flow132.43M247.06M216.97M-20.00K4.73M240.37M

IMCD N.V. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price92.60
Price Trends
50DMA
92.17
Positive
100DMA
100.12
Negative
200DMA
114.68
Negative
Market Momentum
MACD
0.50
Negative
RSI
51.34
Neutral
STOCH
78.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:IMCD, the sentiment is Negative. The current price of 92.6 is above the 20-day moving average (MA) of 91.73, above the 50-day MA of 92.17, and below the 200-day MA of 114.68, indicating a neutral trend. The MACD of 0.50 indicates Negative momentum. The RSI at 51.34 is Neutral, neither overbought nor oversold. The STOCH value of 78.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:IMCD.

IMCD N.V. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
€5.61B20.7714.32%2.32%6.09%-7.18%
€1.01B14.928.84%3.76%-3.45%-5.55%
€10.38B178.421.39%3.31%-2.03%-89.67%
€2.66B8.4311.48%7.40%-4.73%17.93%
$13.29B17.4210.03%0.93%7.13%-12.93%
€744.95M-3.6680.84%
€161.76M-3.15-26.08%-12.31%23.77%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NL:IMCD
IMCD N.V.
92.60
-53.42
-36.58%
NL:AKZA
Akzo Nobel NV
59.76
3.07
5.41%
NL:AVTX
Avantium N.V.
6.42
-9.89
-60.66%
NL:CRBN
Corbion NV
17.04
-5.48
-24.33%
NL:OCI
OCI N.V.
3.47
-0.80
-18.70%
NL:LIGHT
Signify NV
21.08
-0.04
-0.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025